(18)F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing

Verena Ruhlmann1, Thorsten Dirk Poeppel2, Alexander Sascha Brandt3

  • 1Department of Nuclear Medicine, Medical Faculty, University Duisburg-Essen, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany. verena.ruhlmann@uk-essen.de.

Abstract

Insights

Integrated (18)F-FDG PET/MRI offers a comprehensive diagnostic approach for retroperitoneal fibrosis (RPF). This one-stop procedure provides valuable multiparametric data for assessing RPF activity.

Area of Science:

  • Radiology
  • Nuclear Medicine
  • Oncology

Background:

  • Idiopathic retroperitoneal fibrosis (RPF) is a rare condition characterized by inflammatory tissue formation.
  • Accurate assessment of RPF activity is crucial for effective treatment, particularly with steroid therapy.
  • Current diagnostic methods may require multiple imaging modalities.

Purpose of the Study:

  • To evaluate the utility of integrated (18)F-FDG PET/MRI as a single diagnostic procedure for assessing active idiopathic RPF.
  • To compare imaging findings between untreated and treated RPF patients.
  • To correlate imaging parameters with laboratory markers of inflammation.

Main Methods:

  • Seventeen patients with histopathologically confirmed RPF underwent both PET/CT and PET/MRI scans.
  • Patients were categorized into untreated (6) and treated (16) groups.
  • Analysis included visual and quantitative PET (SUVmax, qualitative score) and MRI (T2 signal, contrast enhancement, ADC values) parameters, correlated with ESR and CRP levels.

Main Results:

  • MRI demonstrated restricted diffusion and contrast enhancement in untreated RPF patients more frequently than in treated patients.
  • PET/MRI showed significantly higher FDG uptake (SUVmax and qualitative score) in untreated RPF compared to treated RPF.
  • Strong correlations were observed between ADC values and SUVmax, as well as between ESR/CRP and SUVmax.

Conclusions:

  • Integrated (18)F-FDG PET/MRI serves as a powerful diagnostic tool for evaluating RPF.
  • The technique provides multiparametric information, aiding in the assessment of RPF activity.
  • PET/MRI can be considered a valuable "one-stop" diagnostic procedure for RPF management.

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
8.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
745
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
619